HOME >> BIOLOGY >> NEWS
Familial Cancer Syndrome Linked to Colorectal Cancer in Younger People

Important Factor in Limiting Risk of Additional Cancers in Patients and their Family Members

New York, January 28, 1999 -- Nearly one-fifth of patients who develop colorectal cancer at a young age (40 and younger) have a family history consistent with a familial colorectal cancer syndrome known as hereditary non-polyposis colorectal cancer (HNPCC), according to researchers at Memorial Sloan-Kettering Cancer Center.

The study, published in the current issue of Diseases of the Colon and Rectum, looked at 230 patients 40 years of age and younger who were diagnosed with colorectal cancer and found that nearly 20 percent of them had the HNPCC syndrome.

HNPCC is a dominantly inherited disorder, accounting for about five percent of all colorectal cancer cases. It is generally a fast-growing cancer that affects people primarily in their 40s. People who carry the genetic mutation for HNPCC have an 80 to 85 percent lifetime risk of developing colorectal cancer and are at increased risk of developing endometrial, ovarian, stomach, kidney, and other cancers. The criteria for a clinical diagnosis of HNPCC include: three first-degree relatives with colorectal cancer, spanning two generations, one of whom is less than 50 years of age at the time of diagnosis. This would exclude those with another type of inherited colorectal cancer called Familial Adenomatous Polyposis, a condition where people develop hundreds of colon polyps at a very young age.

"Individuals who develop colorectal cancer at a young age require special surveillance to protect them from developing other types of cancers," said Dr. Jose Guillem, Associate Attending Surgeon at Memorial Sloan-Kettering Cancer Center and lead author of the study. "By identifying and tracking individuals with HNPCC, we can intervene at an early stage and make appropriate, and where warranted, aggressive treatment decisions to prevent the development of additional colorectal and other cance
'"/>

Contact: Stacey Harris
harriss@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
1-Feb-1999


Page: 1 2

Related biology news :

1. Genetic, Familial Factors Influence ADHD, Not Necessarily Sex Of Child
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Cancer gene MYC emerging as key research target
6. Cancer patient, heal thyself
7. USC researcher named General Motors Cancer Research Scholar
8. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
9. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
10. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease
11. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine

Post Your Comments:
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
(Date:5/21/2013)... the way genes function without changing the underlying ... blood of pregnant women during any trimester, potentially ... the weeks after giving birth, and an opportunity ... findings of the small study involving 52 pregnant ... Molecular Psychiatry . , "Postpartum depression can be ...
Breaking Biology News(10 mins):Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
(Date:5/21/2013)... May 21, 2013 The congress ... Transplant Association) is the biggest congress in ... Nearly 10,000 participants are in Istanbul ... research findings. New pioneering studies have been presented: ... PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... Savoury Systems International (SSI), a leader ... to Southeastern USA Sales Broker. Braddy’s new role will ... the Southeast. , In 2004 Braddy founded ... to food processors and industrial manufacturers. Braddy has ... industry and has over 25 years of sales management ...
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
(Date:5/21/2013)... 2013 Smarter Security, Inc., provider of ... announced that Genzyme, a Sanofi company and leading biotech ... CL for a multi-use facility in the United States. ... Genzyme buildings, this latest order underscores the satisfaction and ... detection device improving doorway access control. , ...
Breaking Biology Technology:ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3
Cached News: